The battle against cancer, a global health crisis, has been a tale of two worlds, with remarkable scientific advancements in richer nations leaving millions in poorer countries struggling with devastating consequences. This stark disparity is the focus of a recent World Health Organization (WHO) report, which sheds light on the persistent and widening inequities in cancer care and highlights the urgent need for global action.
One in five people worldwide will develop cancer, and the disease will impact 92% of us, either through personal diagnosis or the diagnosis of a close family member. This is a universal reality, yet the experience of cancer is far from equal. While scientific progress has brought new technologies and treatments, offering hope to many, the report emphasizes that this story is not complete, especially for those in low- and lower-middle-income countries (LMICs).
The numbers are striking. In LMICs, only 9-54% of the WHO's top-20 priority cancer drugs are accessible, compared to 68-94% in high-income countries. This disparity extends to radiation facilities, with 23 countries in LMICs lacking them. Diagnosis rates are lower in sub-Saharan Africa, but cancer-related deaths are disproportionately high, indicating a dire need for improved access to early detection and treatment.
The financial burden of cancer is immense. High costs lead to treatment abandonment in some settings, with up to 90% of patients giving up due to financial constraints. This is a devastating reality, as illustrated by Abigail Simon-Hart, a breast cancer survivor and patient advocate from Nigeria. She shares stories of parents choosing between treatment and education for their children and women opting for early death rather than mastectomies due to stigma. These are not isolated incidents but reflect a systemic issue.
The report also acknowledges the successes in the fight against cancer. The credible path to eliminating cervical cancer and the downward trend in tobacco use are notable achievements. Most countries now have national cancer action plans, indicating a collective effort to address the crisis. However, these successes are overshadowed by the persistent inequities.
The WHO experts call for a shift in perspective, urging the global community to 'value care as highly as cure'. This means recognizing that prevention, diagnosis, and treatment are interconnected and should be funded accordingly. Governments are being urged to prioritize cancer services, ensuring that the benefits of scientific progress are accessible to all.
In my opinion, this report is a wake-up call for the world. It highlights the urgent need for global collaboration to address cancer inequities. While scientific progress is essential, it must be accompanied by equitable access to care. The story of cancer is not complete without addressing the disparities, and the time to act is now. The future of cancer care depends on our collective commitment to ensuring that no one is left behind in the fight against this devastating disease.
